Skip to content

logo

የኢትዮጵያ ምግብና መድኃኒት ባለስልጣን
Ethiopian Food and Drug Authority
  • enEnglish
  • amhአማርኛ
 

FacebookTwitterLinkedin
EFDA
Ethiopian Food and Drug Administration
EFDA
  • Home
  • About Us
    • About EFDA
    • Our Vision, Mission and Objectives
    • Organizational Structure
    • Accreditations
    • Power & Duties
      • Gallery
  • News and Events
  • Services
    • Our Services
    • e-service
    • Traceability
      • FAQ’s
    • Electronic Regulatory Information System(eRIS)
    • e-Reporting of ADR
  • Publications
    • All Publications
    • Policies, Legislation And Regulation
      • Policies
      • Proclamations
      • Regulations
    • Directives and Guidelines
      • Medicine Directives
      • Medical Device Guidelines
      • Medicine Guidelines
      • Cosmetic Directive
      • Food Directives
      • Pharmacovigilance
    • Strategies
    • Manuals
    • Drugs lists and formularies
      • Drug Lists
      • Drug Formulary
    • Bulletins and Newsletter
      • Drug Bulletin
      • Food Bulletin
      • Pharmacovigilance Newsletter
    • Ethiopian public assessment report
    • Ethiopian Traceability System
  • Directorates
    • All Directorates
    • Medicine Registration and Licensing Directorate
    • Medicine Facility Inspection Directorate
    • Food Registration and Licensing Directorate
    • Food Facility Inspection Directorate
    • Food Institution Inspection Directorate
    • Medicine Quality Assessment Directorate
    • Food Quality Assessment Directorate
    • Product Safety Directorate
  • COVID19
    • COVID19 FAQ’s
    • COVID19 publications
    • COVID-19 Quick Access
    • Privacy Policy
  • Announcement
    • Tender
    • Notices
    • Vacancy
  • Contact
    • Uncategorized
  • Home
  • About Us
    • About EFDA
    • Our Vision, Mission and Objectives
    • Organizational Structure
    • Accreditations
    • Power & Duties
      • Gallery
  • News and Events
  • Services
    • Our Services
    • e-service
    • Traceability
      • FAQ’s
    • Electronic Regulatory Information System(eRIS)
    • e-Reporting of ADR
  • Publications
    • All Publications
    • Policies, Legislation And Regulation
      • Policies
      • Proclamations
      • Regulations
    • Directives and Guidelines
      • Medicine Directives
      • Medical Device Guidelines
      • Medicine Guidelines
      • Cosmetic Directive
      • Food Directives
      • Pharmacovigilance
    • Strategies
    • Manuals
    • Drugs lists and formularies
      • Drug Lists
      • Drug Formulary
    • Bulletins and Newsletter
      • Drug Bulletin
      • Food Bulletin
      • Pharmacovigilance Newsletter
    • Ethiopian public assessment report
    • Ethiopian Traceability System
  • Directorates
    • All Directorates
    • Medicine Registration and Licensing Directorate
    • Medicine Facility Inspection Directorate
    • Food Registration and Licensing Directorate
    • Food Facility Inspection Directorate
    • Food Institution Inspection Directorate
    • Medicine Quality Assessment Directorate
    • Food Quality Assessment Directorate
    • Product Safety Directorate
  • COVID19
    • COVID19 FAQ’s
    • COVID19 publications
    • COVID-19 Quick Access
    • Privacy Policy
  • Announcement
    • Tender
    • Notices
    • Vacancy
  • Contact
    • Uncategorized

Archives:

You are here:
  1. Home
  2. Publication

Summary of product Characteristics of Sildenafil Citrate 50

By EFDAJanuary 3, 2023

Summary of product Characteristics of Sildenafil Citrate 50

Public assessment summary report of sildenafil

By EFDAJanuary 3, 2023

Public assessment summary report of sildenafil

Droxiderm SmPC

By EFDANovember 24, 2022

Droxiderm SmPC

Droxiderm PAsRv1

By EFDANovember 24, 2022

Droxiderm PAsRv1

Diclofenac Sodium Injection 75 mg/2 ml Public assessment summary report

By EFDANovember 2, 2022

Diclofenac inj. PAsRv1

SUMMARY OF PRODUCT CHARACTERISTICS DICLOFENAC SODIUM INJECTION 75MG/2ML

By EFDANovember 2, 2022

Diclofenac inj. SmPC V1

Summary of product characteristics for Ritonavir Tablets USP 100 mg

By EFDAOctober 17, 2022

Summary of product characteristics for Ritonavir Tablets USP 100 mg

Summary of product characteristics for Pyrazinamide 150mg Tablets

By EFDAOctober 14, 2022

Summary of product characteristics for Pyrazinamide 150mg Tablets

Summary of product characteristics for DOVPRELA (Pretomanid Tablets 200 mg)

By EFDAOctober 14, 2022

Summary of product characteristics for DOVPRELA (Pretomanid Tablets 200 mg)

Public assessment summary report for DOVPRELA (Pretomanid Tablets 200 mg)

By EFDAOctober 14, 2022

Public assessment summary report for DOVPRELA (Pretomanid Tablets 200 mg)

123
EFDA
Copyright © All rights reserved. EFDA.
Go to Top